Cerus Endovascular secures FDA nod for Contour Neurovascular System trial

Cerus Endovascular will submit the study results in a Premarket Approval (PMA) application to the FDA.(Credit: valelopardo from Pixabay)



Related Article
Recommended Whitepaper

View More